Top Stories CERo Therapeutics Reveals Promising Phase 1 Data at ASTCT Meeting CERo Therapeutics Holdings, Inc. has announced significant findings from its Phase 1 clinical trial, known as CERTAIN-T, during a presentation at the Tandem Meeting... Editorial3 days ago